US 2017/0320850 A1Published application

CRYSTALLINE C21H22Cl2N4O2 MALONATE

AssigneeBiomed Valley Discoveries, Inc.

InventorsGary DeCrescenzo, Dean Welsch, Jon G. Selbo, Ekaterina V. Albert, Emily M. Rigsbee

Life of this patent

Estimating the term…

Abstract

The present invention provides a malonate salt of a compound of formula (I): which is a crystalline salt. Also provided are pharmaceutical compositions that include the provided malonate salt and methods of using the provided crystalline forms and pharmaceutical compositions for the treatment of cancer.

Claims6

Dependent claims

A malonate salt of a compound of formula (I):

which is a crystalline salt.

Dependencies are inferred from the claim text.

Facts

Application: 15/598,160Filed 17 May 2017
Priority: 30 Jan 2015
Published: 9 Nov 2017
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

C07D 401/04
Containing two hetero rings: directly linked by a ring-member-to-ring-member bond
A61K 31/4439
Containing further heterocyclic ring systems: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 25/00
Drugs for disorders of the nervous system

Family

Application62/110,446Us provisional application · filed 30 Jan 2015
Application15/011,420Continuation · filed 29 Jan 2016
Application15/598,160Continuation
US 2016/0221988 A1Published application
US 9,670,177 B2Related patent
US 9,951,041 B2Related patent
US 2017/0320850 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results